GE HealthCare (Nasdaq:GEHC) announced today that it will acquire the remaining 50% stake in Nihon Medi-Physics, enabling it to fully own the Japanese radiopharmaceutical company. The purchase from Sumitomo Chemical is expected to close in early 2025, subject to regulatory approvals. Financial terms of the deal were not disclosed. GE HealthCare has already owned a…

GBI Biomanufacturing announced today that it expanded its drug product (DP) services to include automated sterile fill and finish capabilities. Plantation, Florida–based GBI says it can support clients from clinical trials to commercial launch, both for drug products and drug substances. All of this can take place at its Florida plant, delivering advanced and flexible…

Ardena announced today that it received full Good Manufacturing Practice (GMP) approval of its expanded nanomedicine facility in Oss, The Netherlands. The approval enables the pharmaceutical CDMO to conduct GMP manufacturing operations for nanomedicines. It follows a €20 million investment in a state-of-the-art 45,000-square-foot facility offering GMP-compliant Grade C and Grade D cleanrooms designed specifically…

Sanofi recently announced that it is investing €40 million in its Lyon Gerland bioproduction site as it seeks to bolster its position in the immunology space. The investment will support production in France of the transplant drug Thymoglubulin, including €25 million toward developing and manufacturing a second-generation version of the drug. The remaining €15 million…

Sekisui Diagnostics announced today that its microbial CDMO business completed construction of a £15.7 million ($20.7 million) drug substance manufacturing capacity expansion. The company completed its cGMP capacity expansion at its U.K. site for clinical-grade drug substance manufacturing. Following appropriate licensure, the expansion can enable manufacturing capabilities for common drug types. Those include enzymes, proteins…

A maker of pharma manufacturing workstations says wearable biometric ID products are solving a security and efficiency challenge. Traditionally, pharmaceutical manufacturers have used a complex patchwork of access points, workstations, and tools, according to Fremont, California–based Arista Corp. Think badges, passwords and more, with the potential for someone other than the intended operator to gain…

Otsuka Holdings will pay ICU Medical (Nasdaq: ICUI) an upfront payment of $200 million as part of a joint venture to enter the U.S. IV products market, which has been facing hurricane-related shortages this fall. The partnership — which involves  ICU Medical providing commercial services for Otsuka’s Otsuka Pharmaceutical Factory (OPF) subsidiary — also includes…

Vitrian announced that it closed a $50 million investment into AmplifyBio and its manufacturing enablement center (AMEC) in Ohio. AmplifyBio, a leading advanced therapy CRO and CDMO, offers a full range of drug development and manufacturing services. The investment, which could scale to $65 million, marks a step toward a larger commitment to support biomanufacturing…

Baxter recently stopped selling IV products in China as it continues its efforts to address hurricane-related supply shortages in the U.S. In a statement shared with Pharmaceutical Processing World, the Deerfield, Illinois–based company said: “After careful consideration, and given the numerous alternative IV solution suppliers that exist in the Chinese market, Baxter has suspended commercial…

Terumo Blood and Cell Technologies (BCT) announced that it plans to expand its offerings to Latin America. The company plans to help bring automated manufacturing to cell and gene therapy companies in Brazil, Colombia and Mexico. With a focus on automation, it makes products that collect, process and separate blood and cells. The company also…